Effectiveness of DMF (Dimethyl Fumarate) and Its Impact on PROs (Patient Reported Outcomes) in Treatment-Naive or Suboptimal IFN (Interferon) or GA (Glatiramer Acetate) Responders With RRMS (ImPROve)

NCT02323269 · clinicaltrials.gov ↗
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped 109MS415 ImPROve study was terminated due to patient enrollment challenges and feasibility . The decision was not a result of safety concerns.

Conditions

Interventions

Sponsor

Biogen